Nektar Therapeutics
NKTR
#5687
Rank
โ‚น103.97 B
Marketcap
โ‚น5,112
Share price
-1.37%
Change (1 day)
294.52%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): -โ‚น355.81

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น380.01. In 2024 the company made an earnings per share (EPS) of -โ‚น314.43 an increase over its 2023 EPS that were of -โ‚น1,967.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น355.8113.16%
2024-โ‚น314.43-84.02%
2023-โ‚น1,967-25.89%
2022-โ‚น2,655-31.12%
2021-โ‚น3,85414.86%
2020-โ‚น3,355-1.19%
2019-โ‚น3,396-163.96%
2018โ‚น5,309-725.4%
2017-โ‚น848.95-42.73%
2016-โ‚น1,48283.33%
2015-โ‚น808.5339.53%
2014-โ‚น579.44-69.29%
2013-โ‚น1,887-6.67%
2012-โ‚น2,021

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
โ‚น1,171-408.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น154.52-140.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น682.20-279.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
โ‚น0.90-100.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น272.65-171.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
-โ‚น59.29-84.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
โ‚น185.96-148.94%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
โ‚น937.84-346.79%๐Ÿ‡บ๐Ÿ‡ธ USA